GB0213365D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0213365D0
GB0213365D0 GBGB0213365.0A GB0213365A GB0213365D0 GB 0213365 D0 GB0213365 D0 GB 0213365D0 GB 0213365 A GB0213365 A GB 0213365A GB 0213365 D0 GB0213365 D0 GB 0213365D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0213365.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Glaxo Group Ltd
Original Assignee
GlaxoSmithKline Biologicals SA
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA, Glaxo Group Ltd filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB0213365.0A priority Critical patent/GB0213365D0/en
Publication of GB0213365D0 publication Critical patent/GB0213365D0/en
Priority to PT03757056T priority patent/PT1511768E/en
Priority to RU2004135541/13A priority patent/RU2004135541A/en
Priority to PL03374534A priority patent/PL374534A1/en
Priority to SI200330857T priority patent/SI1511768T1/en
Priority to MXPA04012443A priority patent/MXPA04012443A/en
Priority to NZ537125A priority patent/NZ537125A/en
Priority to EP03757056A priority patent/EP1511768B1/en
Priority to AT03757056T priority patent/ATE359295T1/en
Priority to DE60313163T priority patent/DE60313163T2/en
Priority to JP2004511340A priority patent/JP2006512047A/en
Priority to AU2003246411A priority patent/AU2003246411A1/en
Priority to CNB038194872A priority patent/CN100360558C/en
Priority to CA002487831A priority patent/CA2487831A1/en
Priority to IL16537203A priority patent/IL165372A0/en
Priority to BR0311732-4A priority patent/BR0311732A/en
Priority to KR10-2004-7020138A priority patent/KR20050010040A/en
Priority to ES03757056T priority patent/ES2285174T3/en
Priority to US10/517,420 priority patent/US20060147477A1/en
Priority to PCT/EP2003/006096 priority patent/WO2003104272A1/en
Priority to DK03757056T priority patent/DK1511768T3/en
Priority to PE2003000573A priority patent/PE20040554A1/en
Priority to ARP030102046A priority patent/AR040178A1/en
Priority to MYPI20032146A priority patent/MY139557A/en
Priority to UY27840A priority patent/UY27840A1/en
Priority to TW092115540A priority patent/TW200400970A/en
Priority to IS7547A priority patent/IS7547A/en
Priority to NO20045148A priority patent/NO20045148L/en
Priority to ZA200409863A priority patent/ZA200409863B/en
Priority to CO04122511A priority patent/CO5631450A2/en
Priority to HK05107152A priority patent/HK1074846A1/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0213365.0A 2002-06-11 2002-06-11 Novel compounds Ceased GB0213365D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB0213365.0A GB0213365D0 (en) 2002-06-11 2002-06-11 Novel compounds
DK03757056T DK1511768T3 (en) 2002-06-11 2003-06-06 Immunogenic Compositions
IL16537203A IL165372A0 (en) 2002-06-11 2003-06-06 Immunodenic compositions
ES03757056T ES2285174T3 (en) 2002-06-11 2003-06-06 IMMUNOGENIC COMPOSITIONS.
BR0311732-4A BR0311732A (en) 2002-06-11 2003-06-06 Fusion partner protein, nucleic acid sequence, expression vector, host, immunogenic composition, process for preparing an immunogenic composition, process for producing a fusion protein, use of a protein or DNA sequence, and, Method To Treat A Cancer Patient
SI200330857T SI1511768T1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
MXPA04012443A MXPA04012443A (en) 2002-06-11 2003-06-06 Immunogenic compositions.
NZ537125A NZ537125A (en) 2002-06-11 2003-06-06 Immunogenic compositions
EP03757056A EP1511768B1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
AT03757056T ATE359295T1 (en) 2002-06-11 2003-06-06 IMMUNOGENIC COMPOSITIONS
DE60313163T DE60313163T2 (en) 2002-06-11 2003-06-06 IMMUNOGENIC COMPOSITIONS
RU2004135541/13A RU2004135541A (en) 2002-06-11 2003-06-06 IMMUNOGENIC COMPOSITIONS
AU2003246411A AU2003246411A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
CNB038194872A CN100360558C (en) 2002-06-11 2003-06-06 Immunogenic compositions
CA002487831A CA2487831A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
PT03757056T PT1511768E (en) 2002-06-11 2003-06-06 Immunogenic compositions
PL03374534A PL374534A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
KR10-2004-7020138A KR20050010040A (en) 2002-06-11 2003-06-06 Immunogenic compositions
JP2004511340A JP2006512047A (en) 2002-06-11 2003-06-06 Immunogenic composition
US10/517,420 US20060147477A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
PCT/EP2003/006096 WO2003104272A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
TW092115540A TW200400970A (en) 2002-06-11 2003-06-09 Immunogenic compositions
MYPI20032146A MY139557A (en) 2002-06-11 2003-06-09 A fusion partner protein comprising a choline binding domain and a heterologous promiscuous t helper epitope
ARP030102046A AR040178A1 (en) 2002-06-11 2003-06-09 FUSION COUPLE PROTEIN WITH DOMINION OF UNION TO HILL AND AN AUXILIARY EPITHOPE T PROMISCUO
PE2003000573A PE20040554A1 (en) 2002-06-11 2003-06-09 VACCINES INVOLVING FUSION PROTEINS
UY27840A UY27840A1 (en) 2002-06-11 2003-06-09 VACCINES
IS7547A IS7547A (en) 2002-06-11 2004-11-23 Immunogenic combinations
NO20045148A NO20045148L (en) 2002-06-11 2004-11-25 Immunogenic mixtures
ZA200409863A ZA200409863B (en) 2002-06-11 2004-12-06 Immunogenic compositions
CO04122511A CO5631450A2 (en) 2002-06-11 2004-12-06 IMMUNOGENIC COMPOSITIONS
HK05107152A HK1074846A1 (en) 2002-06-11 2005-08-17 Immunogenic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0213365.0A GB0213365D0 (en) 2002-06-11 2002-06-11 Novel compounds

Publications (1)

Publication Number Publication Date
GB0213365D0 true GB0213365D0 (en) 2002-07-24

Family

ID=9938343

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0213365.0A Ceased GB0213365D0 (en) 2002-06-11 2002-06-11 Novel compounds

Country Status (2)

Country Link
GB (1) GB0213365D0 (en)
ZA (1) ZA200409863B (en)

Also Published As

Publication number Publication date
ZA200409863B (en) 2006-11-29

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0206196D0 (en) Novel compounds
GB0200787D0 (en) Novel compounds
GB0207278D0 (en) Novel compounds
GB0207275D0 (en) Novel compounds
GB0207282D0 (en) Novel compounds
GB0207283D0 (en) Novel compounds
GB0200503D0 (en) Novel compounds
GB0206716D0 (en) Novel compounds
GB0206714D0 (en) Novel compounds
GB0206612D0 (en) Novel compounds
GB0206610D0 (en) Novel compounds
GB0206201D0 (en) Novel compounds
GB0206198D0 (en) Novel compounds
GB0206197D0 (en) Novel compounds
GB0203902D0 (en) Novel compounds
GB0205649D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)